Knowledge Center
Article / Mar 08, 2017
Expanding the Commercial Options
Source:
Pharma's Almanac, Q1 2017, Mar 8, 2017
Spray drying (SD) and hot-melt extrusion (HME) are commercially proven and accepted amorphous solid dispersion (ASD) technologies for the enhancement of the dissolution and bioavailability of poorly soluble drugs. These approaches are not suitable for all APIs, however. ËÄÉ«AV, in addition to offering non-ASD solutions such as nanomilling and cyclodextrin complexation, is developing an effective coprecipitation technology platform to address this key market need.
Related links
Also in the Knowledge Center
Scientific Article
/ Oct 18, 2021
Ring Shear Tester: The importance of Shear and Wall Friction Methodology for Arching Tendency Predictions
Read more
Scientific Article
/ Oct 13, 2021
Evaluation of the Relaxation State of Amorphous Itraconazole Using Solution Calorimetry
Read more
Scientific Article